The answer to your question very mich depends on t
Post# of 36537
(Total Views: 253)
Posted On: 05/11/2020 8:03:53 AM
The answer to your question very mich depends on the news that we will or will not receive until the first Nasdaq trading day of NGIO.
Should BARDA approve the application and provide 50+ mill. funding, I am conviced that GNBT /NGIO will be able to follow suit with the plan to have a vaccine before the end of the year. If that is the case, then "the sky is the limit", just imagine the publicity - WORLDWIDE - if GNBT would be the first, and - for a couple of months - ONLY company to have an approved and mass produced vaccine!!
Should BARDA approve the application and provide 50+ mill. funding, I am conviced that GNBT /NGIO will be able to follow suit with the plan to have a vaccine before the end of the year. If that is the case, then "the sky is the limit", just imagine the publicity - WORLDWIDE - if GNBT would be the first, and - for a couple of months - ONLY company to have an approved and mass produced vaccine!!
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼